{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T16:07:51Z","timestamp":1787933271732,"version":"build-2784847793"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>In 2022, the presumption of monkeypox (mpox) to be of limited epidemiology shifted when a global outbreak was announced. Being a member of the Orthopoxvirus genus in the Poxviridae family, it\u2019d been reported in over 82 countries with over 17 000 confirmed cases by July 2022, thus showing its capability for spreading rapidly. As the smallpox vaccine offers 85% cross-immunity against mpox, the outbreak highlighted the attenuation of global immunity against orthopoxviruses after the cessation of vaccination campaigns against smallpox. The mortality of this virus is higher in vulnerable populations such as children, pregnant women, the elderly, and immunosuppressed individuals. With treatment methods being limited to off-label use of antivirals, the need for urgent and efficient preventative measures is emphasized. At present, JYNNEOS (Modified Vaccinia Ankara-Bavarian Nordic), showing favorable safety, and ACAM2000, a live attenuated virus with a high risk of side effects, are two vaccines that are indicated for mpox immunization. However, neither of them has proven full safety, efficacy, and widespread accessibility against mpox. Hence, the use of mRNA vaccines has emerged as a better alternative to traditional vaccinations, as they leverage synthetic messenger RNA to instruct host cells to produce antigens, eliciting both humoral and cellular immune responses. Though they provided rapid scalability, adaptability to emerging viral variants, and an established safety profile after the COVID-19 pandemic, their usage in preventing mpox remains an area of research. This paper elucidates the potential of mRNA technology to address the unmet needs in mpox prevention. It also highlights the need for genomic surveillance, immunological insights, and innovative delivery systems.<\/jats:p>","DOI":"10.1097\/ms9.0000000000003558","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:13:39Z","timestamp":1752156819000},"page":"5650-5660","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Potential of MRNA vaccines for mpox prevention: current evidence and future directions"],"prefix":"10.1097","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0153-287X","authenticated-orcid":false,"given":"Toufik","family":"Abdul-Rahman","sequence":"first","affiliation":[{"name":"Department of Research, Toufik\u2019s World Organization, Sumy, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ogungbemi Evelyn","family":"Faith","sequence":"additional","affiliation":[{"name":"Department of Research, Toufik\u2019s World Organization, Sumy, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oyinbolaji Akinwande","family":"Ajetunmobi","sequence":"additional","affiliation":[{"name":"Department of Research, Toufik\u2019s World Organization, Sumy, Ukraine"},{"name":"Department of Public and International Affairs, University of Lagos, Akoka, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala Ibrahim","family":"Thaalibi","sequence":"additional","affiliation":[{"name":"Department of Research, Toufik\u2019s World Organization, Sumy, Ukraine"},{"name":"Faculty of Medicine, Beirut Arab University, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinelo Geraldine","family":"Ikele","sequence":"additional","affiliation":[{"name":"Department of Research, Toufik\u2019s World Organization, Sumy, Ukraine"},{"name":"Department of Veterinary Medicine, University of Nigeria, Nsukka, Enugu State, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gargi","family":"Gautam","sequence":"additional","affiliation":[{"name":"Department of Research, Toufik\u2019s World Organization, Sumy, Ukraine"},{"name":"Department of Medicine, Georgian National University SEU, Tbilisi, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith Olanrewaju","family":"Omotayo","sequence":"additional","affiliation":[{"name":"Department of Research, Toufik\u2019s World Organization, Sumy, Ukraine"},{"name":"Department of Pharmacy, Ekiti State University Teaching Hospital, Ado Ekiti, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poulami","family":"Roy","sequence":"additional","affiliation":[{"name":"Department of Research, Toufik\u2019s World Organization, Sumy, Ukraine"},{"name":"Department of Medicine, North Bengal Medical College and Hospital, Siliguri, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alhazan Amir","family":"Adebayo","sequence":"additional","affiliation":[{"name":"Department of Research, Toufik\u2019s World Organization, Sumy, Ukraine"},{"name":"Department of Electrical and Biomedical Engineering, Abiola Ajimobi Technical University, Ibadan, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muslimat Abolore","family":"Mojeed","sequence":"additional","affiliation":[{"name":"Department of Research, Toufik\u2019s World Organization, Sumy, Ukraine"},{"name":"Physiotherapy Department, University of Lagos, Lagos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolulope Taiwo","family":"Kareem","sequence":"additional","affiliation":[{"name":"Department of Research, Toufik\u2019s World Organization, Sumy, Ukraine"},{"name":"Microbiology, Abubakar Tafawa Balewa University, Bauchi State, Bauchi, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halima Ibrahim","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Research, Toufik\u2019s World Organization, Sumy, Ukraine"},{"name":"Nursing Department, Comboni College of Science and Technology, Khartoum, Sudan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Grace","family":"Atieno","sequence":"additional","affiliation":[{"name":"Department of Research, Toufik\u2019s World Organization, Sumy, Ukraine"},{"name":"Department of Pediatrics, Maseno University School of Medicine, Kisumu, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Oluwafeyisayo","family":"Ademeta","sequence":"additional","affiliation":[{"name":"Department of Research, Toufik\u2019s World Organization, Sumy, Ukraine"},{"name":"Medicine and Surgery, University of Novi Sad, Novi Sad, Serbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Garg","sequence":"additional","affiliation":[{"name":"Department of Research, Toufik\u2019s World Organization, Sumy, Ukraine"},{"name":"Rowan-Virtua School of Osteopathic Medicine, One Medical Center Drive, Stratford, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ashinze","sequence":"additional","affiliation":[{"name":"Department of Research, Toufik\u2019s World Organization, Sumy, Ukraine"},{"name":"Faculty of Clinical Sciences, University of Ilorin, Ilorin, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godfred Yawson","family":"Scott","sequence":"additional","affiliation":[{"name":"Department of Research, Toufik\u2019s World Organization, Sumy, Ukraine"},{"name":"Department of Medical Diagnostics, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"R1-20251007","doi-asserted-by":"crossref","first-page":"e30406","DOI":"10.1097\/MD.0000000000030406","article-title":"Human monkeypox virus: an updated review","volume":"101","author":"Adnan","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"R2-20251007","doi-asserted-by":"crossref","first-page":"597\u2013613","DOI":"10.1038\/s41577-022-00775-4","article-title":"Monkeypox: disease epidemiology, host immunity and clinical interventions","volume":"22","author":"Lum","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"R4-20251007","doi-asserted-by":"crossref","first-page":"73\u201375","DOI":"10.1093\/jpids\/piac120","article-title":"Monkeypox emergence and the eradication of smallpox: an historical review","volume":"12","author":"Shulman","year":"2023","journal-title":"J Pediatr Infect Dis Soc"},{"key":"R5-20251007","doi-asserted-by":"crossref","first-page":"p1190","DOI":"10.1136\/bmj.p1190","article-title":"WHO ends public health emergency designation for mpox","volume":"381","author":"Carlson","year":"2023","journal-title":"BMJ"},{"key":"R6-20251007","doi-asserted-by":"crossref","first-page":"1005955","DOI":"10.3389\/fcimb.2022.1005955","article-title":"Monkeypox 2022 outbreak in non-endemic countries: open questions relevant for public health, nonpharmacological intervention and literature review","volume":"12","author":"Capobianchi","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"R7-20251007","doi-asserted-by":"crossref","first-page":"976\u201384","DOI":"10.1016\/j.vaccine.2006.09.046","article-title":"An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies","volume":"25","author":"Wiser","year":"2007","journal-title":"Vaccine"},{"key":"R8-20251007","doi-asserted-by":"crossref","first-page":"100397","DOI":"10.1016\/j.clinpr.2024.100397","article-title":"Clinical manifestations and outcomes of human mpox infection from 1970 to 2023: a systematic literature review","volume":"24","author":"Abejegah","year":"2024","journal-title":"Clin Infect Pract"},{"key":"R10-20251007","doi-asserted-by":"crossref","first-page":"331\u201344","DOI":"10.1080\/14787210.2020.1819791","article-title":"An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications","volume":"19","author":"Russo","year":"2021","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R11-20251007","doi-asserted-by":"crossref","first-page":"416\u201325","DOI":"10.1056\/NEJMsa025075","article-title":"A model for a smallpox-vaccination policy","volume":"348","author":"Bozzette","year":"2003","journal-title":"N Engl J Med"},{"key":"R12-20251007","doi-asserted-by":"crossref","first-page":"110206","DOI":"10.1016\/j.intimp.2023.110206","article-title":"Efficacy of the modified vaccinia ankara virus vaccine and the replication-competent vaccine ACAM2000 in monkeypox prevention","volume":"119","author":"Kandeel","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"R13-20251007","doi-asserted-by":"crossref","first-page":"2434\u201343","DOI":"10.1056\/NEJMoa2215201","article-title":"Vaccine effectiveness of JYNNEOS against mpox disease in the United States","volume":"388","author":"Deputy","year":"2023","journal-title":"N Engl J Med"},{"key":"R14-20251007","doi-asserted-by":"crossref","first-page":"2879\u201386","DOI":"10.1016\/j.vaccine.2023.03.054","article-title":"Real-life safety profile of mRNA vaccines for COVID-19: an analysis of VAERS database","volume":"41","author":"Santi Laurini","year":"2023","journal-title":"Vaccine"},{"key":"R15-20251007","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3390\/vaccines9070734","article-title":"Detailed dissection and critical evaluation of the pfizer\/BioNTech and moderna mRNA vaccines","volume":"9","author":"Xia","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"R16-20251007","doi-asserted-by":"crossref","first-page":"2204151","DOI":"10.1080\/22221751.2023.2204151","article-title":"Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge","volume":"12","author":"Zeng","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"R18-20251007","doi-asserted-by":"crossref","first-page":"1100\u201312","DOI":"10.3390\/v7031100","article-title":"The origin of the variola virus","volume":"7","author":"Babkin","year":"2015","journal-title":"Viruses"},{"key":"R19-20251007","doi-asserted-by":"crossref","first-page":"118\u201321","DOI":"10.1177\/003693309704200407","article-title":"Edward jenner and the eradication of smallpox","volume":"42","author":"Willis","year":"1997","journal-title":"Scott Med J"},{"key":"R20-20251007","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.20883\/medical.e750","article-title":"Multi-epitope mRNA vaccine design that exploits variola virus and monkeypox virus proteins for elicitation of long-lasting humoral and cellular protection against severe disease","author":"Kova\u010di\u0107","year":"2022","journal-title":"J Med Sci"},{"key":"R21-20251007","doi-asserted-by":"crossref","first-page":"4261\u201365","DOI":"10.1016\/j.vaccine.2007.02.076","article-title":"The introduction of variolation \u201cA la turca\u201d to the west by lady mary montagu and turkey\u2019s contribution to this","volume":"25","author":"Dinc","year":"2007","journal-title":"Vaccine"},{"key":"R22-20251007","first-page":"100","article-title":"Vaccination of the ethnic greeks (Rums) against smallpox in the ottoman empire: emmanuel timonis and jacobus pylarinos as precursors of edward jenner","volume":"43","author":"Kyrkoudis","year":"2021","journal-title":"J Clin Pract Res"},{"key":"R24-20251007","doi-asserted-by":"crossref","first-page":"7222\u201330","DOI":"10.1016\/j.vaccine.2017.11.003","article-title":"Equination (inoculation of horsepox): an early alternative to vaccination (inoculation of cowpox) and the potential role of horsepox virus in the origin of the smallpox vaccine","volume":"35","author":"Esparza","year":"2017","journal-title":"Vaccine"},{"key":"R25-20251007","doi-asserted-by":"crossref","first-page":"4773\u201379","DOI":"10.1016\/j.vaccine.2020.05.037","article-title":"Early smallpox vaccine manufacturing in the United States: introduction of the \u201canimal vaccine\u201d in 1870, establishment of \u201cvaccine farms\u201d, and the beginnings of the vaccine industry","volume":"38","author":"Esparza","year":"2020","journal-title":"Vaccine"},{"key":"R26-20251007","doi-asserted-by":"crossref","first-page":"398\u2013409","DOI":"10.1016\/S0140-6736(05)70234-8","article-title":"Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial","volume":"365","author":"Greenberg","year":"2005","journal-title":"Lancet"},{"key":"R27-20251007","doi-asserted-by":"crossref","first-page":"2384189","DOI":"10.1080\/21645515.2024.2384189","article-title":"Equivalence of freeze-dried and liquid-frozen formulations of MVA-BN as smallpox and mpox vaccine","volume":"20","author":"Greenberg","year":"2024","journal-title":"Hum Vaccines Immunother"},{"key":"R28-20251007","doi-asserted-by":"crossref","first-page":"1\u201313","DOI":"10.1016\/j.antiviral.2009.06.006","article-title":"Vaccinia virus vaccines: past, present and future","volume":"84","author":"Jacobs","year":"2009","journal-title":"Antiviral Res"},{"key":"R29-20251007","doi-asserted-by":"crossref","first-page":"71\u201380","DOI":"10.1006\/viro.1998.9516","article-title":"Neutralizing and protective antibodies directed against vaccinia virus envelope antigens","volume":"254","author":"Galmiche","year":"1999","journal-title":"Virology"},{"key":"R30-20251007","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1038\/s41598-018-24820-2","article-title":"Effects of pre-existing orthopoxvirus-specific immunity on the performance of modified vaccinia virus ankara-based influenza vaccines","volume":"8","author":"Altenburg","year":"2018","journal-title":"Sci Rep"},{"key":"R31-20251007","doi-asserted-by":"crossref","first-page":"2627\u201331","DOI":"10.1128\/jvi.70.4.2627-2631.1996","article-title":"Human cytotoxic T-cell memory: long-lived responses to vaccinia virus","volume":"70","author":"Demkowicz","year":"1996","journal-title":"J Virol"},{"key":"R32-20251007","doi-asserted-by":"crossref","first-page":"3329\u201337","DOI":"10.1128\/JVI.76.7.3329-3337.2002","article-title":"Recombinant vaccinia virus-induced T-cell immunity: quantitation of the response to the virus vector and the foreign epitope","volume":"76","author":"Harrington","year":"2002","journal-title":"J Virol"},{"key":"R33-20251007","doi-asserted-by":"crossref","first-page":"D74","DOI":"10.1016\/j.vaccine.2012.01.080","article-title":"The expanded programme on immunization: a lasting legacy of smallpox eradication","volume":"29","author":"Okwo-Bele","year":"2011","journal-title":"Vaccine"},{"key":"R34-20251007","first-page":"397\u2013420","article-title":"Smallpox: emergence, global spread, and eradication","volume":"15","author":"Fenner","year":"1993","journal-title":"Hist Philos Life Sci"},{"key":"R35-20251007","doi-asserted-by":"crossref","first-page":"766\u201374","DOI":"10.1086\/374244","article-title":"Progressive vaccinia","volume":"36","author":"Bray","year":"2003","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"R36-20251007","doi-asserted-by":"crossref","first-page":"1021\u201335","DOI":"10.1586\/erv.11.46","article-title":"The strategic use of novel smallpox vaccines in the post-eradication world","volume":"10","author":"Golden","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"R37-20251007","first-page":"55\u201382","article-title":"Replication and expression strategies of viruses","volume":"10","author":"Rampersad","year":"2018","journal-title":"Viruses"},{"key":"R38-20251007","doi-asserted-by":"crossref","first-page":"109270","DOI":"10.1016\/j.cclet.2023.109270","article-title":"An MPXV mRNA-LNP vaccine candidate elicits protective immune responses against monkeypox virus","volume":"35","author":"Tian","year":"2024","journal-title":"Chin Chem Lett"},{"key":"R39-20251007","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3390\/v15051120","article-title":"Development of a multi-epitope universal mRNA vaccine candidate for monkeypox, smallpox, and vaccinia viruses: design and in silico analyses","volume":"15","author":"Rcheulishvili","year":"2023","journal-title":"Viruses"},{"key":"R40-20251007","doi-asserted-by":"crossref","first-page":"43341\u201355","DOI":"10.1021\/acsomega.3c07866","article-title":"Deciphering the immunogenicity of monkeypox proteins for designing the potential mRNA vaccine","volume":"8","author":"Shah","year":"2023","journal-title":"ACS Omega"},{"key":"R41-20251007","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1038\/s41467-023-41628-5","article-title":"mRNA vaccines encoding fusion proteins of monkeypox virus antigens protect mice from vaccinia virus challenge","volume":"14","author":"Hou","year":"2023","journal-title":"Nat Commun"},{"key":"R42-20251007","doi-asserted-by":"crossref","first-page":"102550","DOI":"10.1016\/j.tmaid.2023.102550","article-title":"mRNA vaccines as an armor to combat the infectious diseases","volume":"52","author":"Null","year":"2023","journal-title":"Travel Med Infect Dis"},{"key":"R43-20251007","first-page":"817\u201338","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"R44-20251007","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41392-023-01432-5","article-title":"Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus","volume":"8","author":"Sang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"R45-20251007","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1016\/j.cell.2024.08.043","article-title":"Comparison of protection against mpox following mRNA or modified vaccinia ankara vaccination in nonhuman primates","volume":"187","author":"Mucker","year":"2024","journal-title":"Cell"},{"key":"R46-20251007","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.3390\/vaccines10091419","article-title":"Preventing the next pandemic: is live vaccine efficacious against monkeypox, or is there a need for killed virus and mRNA vaccines?","volume":"10","author":"Abdelaal","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"R47-20251007","doi-asserted-by":"crossref","first-page":"589\u201393","DOI":"10.1038\/s41586-020-2639-4","article-title":"Phase I\/II study of COVID-19 RNA vaccine BNT162b1 in adults","volume":"586","author":"Mulligan","year":"2020","journal-title":"Nature"},{"key":"R48-20251007","doi-asserted-by":"crossref","first-page":"171\u201377","DOI":"10.1016\/j.antiviral.2018.11.004","article-title":"Vaccinating against monkeypox in the democratic republic of the congo","volume":"162","author":"Petersen","year":"2019","journal-title":"Antiviral Res"},{"key":"R49-20251007","doi-asserted-by":"crossref","first-page":"1897\u2013908","DOI":"10.1056\/NEJMoa1817307","article-title":"Phase 3 efficacy trial of modified vaccinia ankara as a vaccine against smallpox","volume":"381","author":"Pittman","year":"2019","journal-title":"N Engl J Med"},{"key":"R50-20251007","doi-asserted-by":"crossref","first-page":"433\u201338","DOI":"10.24171\/j.phrp.2023.0182","article-title":"JYNNEOS vaccine safety monitoring in the Republic of Korea, 2022: a cross-sectional study","volume":"14","author":"Lee","year":"2023","journal-title":"Osong Public Health Res Perspect"},{"key":"R51-20251007","doi-asserted-by":"crossref","first-page":"1144325","DOI":"10.3389\/fpubh.2023.1144325","article-title":"Characterization of interventional clinical trials for monkeypox; systematic review of clinicaltrials.gov database","volume":"11","author":"Alorfi","year":"2023","journal-title":"Front Public Health"},{"key":"R52-20251007","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41392-023-01579-1","article-title":"mRNA vaccines in disease prevention and treatment","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"R53-20251007","doi-asserted-by":"crossref","first-page":"553\u201358","DOI":"10.15585\/mmwr.mm7220a3","article-title":"Estimated effectiveness of JYNNEOS vaccine in preventing mpox: a multijurisdictional case-control study - United States, August 19, 2022-March 31, 2023","volume":"72","author":"Dalton","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R54-20251007","doi-asserted-by":"crossref","first-page":"289\u2013303","DOI":"10.1016\/j.vaccine.2010.10.039","article-title":"Impact of ST-246\u00ae on ACAM2000TM smallpox vaccine reactogenicity, immunogenicity, and protective efficacy in immunodeficient mice","volume":"29","author":"Berhanu","year":"2010","journal-title":"Vaccine"},{"key":"R55-20251007","first-page":"71","article-title":"Receipt of first and second doses of JYNNEOS vaccine for prevention of monkeypox \u2014 United States, May 22\u2013October 10, 2022","author":"Kriss","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R56-20251007","first-page":"71","article-title":"Safety monitoring of JYNNEOS vaccine during the 2022 mpox outbreak \u2014 United States, May 22\u2013October 21, 2022","author":"Duffy","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R57-20251007","doi-asserted-by":"crossref","first-page":"261\u201379","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2014 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"R59-20251007","doi-asserted-by":"crossref","first-page":"257\u201362","DOI":"10.15585\/mmwr.mm6510a2","article-title":"Use of vaccinia virus smallpox vaccine in laboratory and health care personnel at risk for occupational exposure to orthopoxviruses \u2014 recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015","volume":"65","author":"Petersen","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R60-20251007","doi-asserted-by":"crossref","first-page":"460\u201366","DOI":"10.15585\/mmwr.mm7320a3","article-title":"Monkeypox virus infections after 2 preexposure doses of JYNNEOS vaccine - United States, May 2022-May 2024","volume":"73","author":"Guagliardo","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R61-20251007","doi-asserted-by":"crossref","first-page":"1637\u201344","DOI":"10.1016\/j.vaccine.2008.11.079","article-title":"Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and dryvax in healthy vaccinia-naive adults","volume":"27","author":"Frey","year":"2009","journal-title":"Vaccine"},{"key":"R62-20251007","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/pharmaceutics12020102","article-title":"Opportunities and challenges in the delivery of mRNA-based vaccines","volume":"12","author":"Wadhwa","year":"2020","journal-title":"Pharmaceutics"},{"key":"R64-20251007","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.3390\/pharmaceutics15071972","article-title":"Recent advancement in mRNA vaccine development and applications","volume":"15","author":"Al Fayez","year":"2023","journal-title":"Pharmaceutics"},{"key":"R65-20251007","first-page":"100047","article-title":"Exploring the challenges of the COVID-19 vaccine supply chain using social media analytics: a global perspective","volume":"2","author":"Cano-Marin","year":"2023","journal-title":"Sustain Technol Entrep"},{"key":"R66-20251007","doi-asserted-by":"crossref","first-page":"2190\u2013200","DOI":"10.1016\/j.vaccine.2021.03.038","article-title":"mRNA vaccines manufacturing: challenges and bottlenecks","volume":"39","author":"Rosa","year":"2021","journal-title":"Vaccine"},{"key":"R67-20251007","doi-asserted-by":"crossref","first-page":"7084\u201388","DOI":"10.1016\/j.vaccine.2023.07.021","article-title":"Equitable global allocation of monkeypox vaccines","volume":"41","author":"Schaefer","year":"2023","journal-title":"Vaccine"},{"key":"R68-20251007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/vaccines11010011","article-title":"COVID-19 vaccines: how efficient and equitable was the initial vaccination process?","volume":"11","author":"Das","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"R69-20251007","doi-asserted-by":"crossref","first-page":"101313","DOI":"10.1016\/j.cegh.2023.101313","article-title":"Monkeypox vaccination in the global south: fighting a war without a weapon","volume":"22","author":"Ogunkola","year":"2023","journal-title":"Clin Epidemiol Glob Health"},{"key":"R70-20251007","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-022-00950-y","article-title":"Advances in COVID-19 mRNA vaccine development","volume":"7","author":"Fang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"R71-20251007","doi-asserted-by":"crossref","first-page":"403\u201316","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"R72-20251007","doi-asserted-by":"crossref","first-page":"245\u201362","DOI":"10.1007\/s12272-022-01381-7","article-title":"mRNA vaccines: the most recent clinical applications of synthetic mRNA","volume":"45","author":"Kwon","year":"2022","journal-title":"Arch Pharm Res"},{"key":"R73-20251007","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12967-019-1804-8","article-title":"How mRNA therapeutics are entering the monoclonal antibody field","volume":"17","author":"Van Hoecke","year":"2019","journal-title":"J Transl Med"},{"key":"R74-20251007","doi-asserted-by":"crossref","first-page":"1172691","DOI":"10.3389\/fimmu.2023.1172691","article-title":"mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV","volume":"14","author":"Matarazzo","year":"2023","journal-title":"Front Immunol"},{"key":"R75-20251007","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3390\/vaccines10081262","article-title":"Application of mRNA technology in cancer therapeutics","volume":"10","author":"Eralp","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"R76-20251007","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3390\/vaccines9091033","article-title":"Challenges of storage and stability of mRNA-based COVID-19 vaccines","volume":"9","author":"Uddin","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"R77-20251007","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.3390\/v16121815","article-title":"Challenges in global distribution and equitable access to monkeypox vaccines","volume":"16","author":"Danladi","year":"2024","journal-title":"Viruses"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:02:01Z","timestamp":1759827721000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000003558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":71,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000003558","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"2025-04-25","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}